Patent Assignment
Reel/Frame 027261/0928
Release of Security Interest
Recorded: 2011-11-18
Pages: 12
Assignor
JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Executed: 2011-11-14
Assignees
MYLAN TECHNOLOGIES, INC.
110 LAKE STREET, ST. ALBANS, VERMONT, 05478
DEY, INC. (F/K/A DEY LABORATORIES, INC.)
110 ALLEN ROAD, BASKING RIDGE, NEW JERSEY, 07920
MYLAN BERTEK PHARMACEUTICALS INC.
12720 DAIRY ASHFORD, SUGARLAND, TEXAS, 77478
MYLAN PHARMACEUTICALS, INC.
781 CHESTNUT RIDGE ROAD, P.O. BOX 4310, MORGANTOWN, WEST VIRGINIA, 26505
DEY PHARMA, L.P. (F/K/A DEY L.P.)
110 ALLEN ROAD, BASKING RIDGE, NEW JERSEY, 07920
MYLAN INSTITUTION INC. (F/K/A UDL LABORATORIES, INC.)
1718 NORTHROCK CT., ROCKFORD, ILLINOIS, 61103
MYLAN INC. (F/K/A MYLAN LABORATORIES INC.)
1500 CORPORATE DRIVE, CANONSBURG, PENNSYLVANIA, 15317
Covered Properties
(80)
Liquid Dispensing Container
Patent:
275,732 →
Application:
06/380,924 →
Liquid Dispensing Container
Patent:
289,609 →
Application:
06/676,494 →
Liquid Dispensing Container
Patent:
296,869 →
Application:
06/777,199 →
Method of Making Laminated Articles and Articles Made Therefrom
Patent:
4,854,610 →
Application:
07/154,951 →
Hinged Dermal Applicator
Patent:
4,915,102 →
Application:
07/239,592 →
Liquid Dispensing Container
Patent:
317,715 →
Application:
07/418,456 →
Stabilized Sulfite-Free Catecholamine Compositions
Patent:
5,002,973 →
Application:
07/426,495 →
Method for the Cleansing of Wounds an Aerosol Container Having Liquid Wound Cleansing Solution
Patent:
5,059,187 →
Application:
07/518,244 →
Twin Patch Applicator
Patent:
5,064,422 →
Application:
07/599,686 →
Moisture Permeable Double Disk
Patent:
5,123,900 →
Application:
07/746,764 →
Retinoic Acid-Containing Polyether-Polyurethane Compositions
Patent:
5,650,171 →
Application:
07/875,772 →
Foam Laminate Transdermal Patch
Patent:
5,503,844 →
Application:
08/063,515 →
Adhesive Dressing Applicator
Patent:
5,840,052 →
Application:
08/379,863 →
Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent
Patent:
5,662,926 →
Application:
08/426,492 →
Packaging System for Medication
Patent:
35,445 →
Application:
08/445,778 →
Foam Laminate Transdermal Patch
Patent:
5,629,014 →
Application:
08/476,418 →
Process of Assembling a Transdermal Patch Incorporation a Polymer Film Incorporated with an Active Agent
Patent:
5,679,373 →
Application:
08/477,042 →
Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent
Patent:
5,676,969 →
Application:
08/477,312 →
Retinoic Acid-Containing Compositions
Patent:
5,700,483 →
Application:
08/708,181 →
Adhesive Mixture for Transdermal Delivery of Highly Plasticizing Drugs
Transdermal Patch
Patent:
5,948,433 →
Application:
08/918,526 →
Antifungal/Steroid Topical Compositions
Patent:
6,075,056 →
Application:
08/943,574 →
Transdermal Patch Incorporating a Polymer Film Incorporated with an Active Agent
Patent:
6,010,715 →
Application:
08/954,861 →
Pharmaceutical Composition Containing Bupropion Hydrochloride and an Inorganic Acid Stabilizer
Patent:
5,968,553 →
Application:
09/000,673 →
Pharmaceutical Composition Containing Bupropion Hydrochloride and a Stabilizer
Patent:
6,221,917 →
Application:
09/000,999 →
Polyurethanes as Topical Skin Protectants
Patent:
6,277,364 →
Application:
09/169,208 →
Stabilized Injectable Pharmaceutical Compositions Containing Taxoid Anti-Neoplastic Agents
Patent:
6,071,952 →
Application:
09/203,350 →
Phenytoin Sodium Pharmaceutical Compositions
Patent:
6,274,168 →
Application:
09/255,705 →
Use of Vitamin D Analogs to Treat Conditions Related to Increased Oxidative Stress
Patent:
6,262,041 →
Application:
09/287,544 →
Topical Formulations for the Treatment of Nail Fungal Diseases
Patent:
6,143,794 →
Application:
09/289,205 →
Pharmaceutical Composition Containing Bupropion Hydrochloride and a Stabilizer
Patent:
6,242,496 →
Application:
09/406,906 →
Stabilized Injectable Pharmaceutical Compositions Containing Taxoid Anti-Neoplastic Agents
Patent:
6,153,644 →
Application:
09/432,084 →
Adhesive Mixture for Transdermal Delivery of Highly Plasticizing Drugs
Pharmaceutical Composition Containing Bupropion Hydrochloride and a Stabilizer
Phenytoin Sodium Pharmaceutical Compositions
Bronchodilating Compositions and Methods
Formoterol/steroid bronchodilating compositions and methods of use thereof
Application:
09/887,496 →
Publication:
US 2003/0055026
Storage Stable Thyroxine Active Drug Formulations and Methods for Their Production
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
Application:
10/034,657 →
Albuterol Inhalation Solution, System, Kit and Method for Relieving Symptoms of Pediatric Asthma
Bronchodilating Compositions and Methods
Formoterol/steroid bronchodilating compositions and methods of use thereof
Application:
10/145,978 →
Publication:
US 2002/0183293
Albuterol and Ipratropium Inhalation Solution, System, Kit and Method for Relieving Symptoms of Chronic Obstructive Pulmonary Disease
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
Application:
10/274,467 →
Publication:
US 2003/0140920
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
Application:
10/283,355 →
Publication:
US 2004/0086551
Nasal pharmaceutical formulations and methods of using the same
Nasal Pharmaceutical Formulations and Methods of Using the Same
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
Application:
10/417,723 →
Publication:
US 2003/0203930
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
Application:
10/417,726 →
Publication:
US 2003/0191151
Storage Stable Thyroxine Active Drug Formulations and Methods for Their Production
Storage Stable Thyroxine Active Drug Formulations and Methods for Their Production
Inhalable formulations for treating pulmonary hypertension and methods of using same
Application:
10/609,233 →
Publication:
US 2004/0265238
Transdermal Patch Incorporating Active Agent Migration Barrier Layer
Formulations and methods for treating rhinosinusitis
Adhesive Mixture for Transdermal Delivery of Highly Plasticizing Drugs
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
Application:
10/795,584 →
Publication:
US 2005/0202073
Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
Application:
10/800,031 →
Publication:
US 2005/0202079
Bronchodilating Beta-Agonist Compositions and Methods
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
Application:
11/013,491 →
Publication:
US 2005/0175544
Formulations and Methods for Treating Rhinosinusitis
Compositions Comprising Nebivolol
Storage Stable Thyroxine Active Drug Formulations and Methods for Their Production
Compositions comprising nebivolol
Application:
11/272,562 →
Compositions Comprising Nebivolol
Two-Sided Non-Stick Release Film
Hydroxylated nebivolol metabolites
Application:
11/342,497 →
Publication:
US 2007/0014733
Glucuronidated nebivolol metabolites
Application:
11/342,889 →
Publication:
US 2007/0014734
Long-Wearing Removable Pressure Sensitive Adhesive
Bronchodilating Beta-Agonist Compositions and Methods
Bronchodilating Beta-Agonist Compositions and Methods
Bronchodilating Beta-Agonist Compositions and Methods
Bronchodilating Beta-Agonist Compositions and Methods
Storage stable thyroxine active drug formulations and methods for their production
Application:
11/699,456 →
Publication:
US 2007/0122476
Extended-release dosage form
Application:
11/701,178 →
Publication:
US 2008/0187579
Fentanyl Suspension-Based Silicone Adhesive Formulations and Devices for Transdermal Delivery of Fentanyl
Application:
11/723,111 →
Publication:
US 2007/0166365
Amorphous drug transdermal systems, manufacturing methods, and stabilization
Application:
11/725,159 →
Publication:
US 2008/0226698
Fentanyl Suspension-Based Silicone Adhesive Formulations and Devices for Transdermal Delivery of Fentanyl
Application:
11/743,411 →
Publication:
US 2007/0259027
Drug Formulations Having Inert Sealed Cores
Stabilized Tolterodine Tartrate Formulations
Nebulizable Compositions of Quaternary Ammonium Muscarinic Receptor Antagonists
Application:
60/803,309 →
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement
Nov 21, 2011
From: MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.; MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.)
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027270/0799 →
Change of Name
Dec 8, 2011
From: BERTEK PHARMACEUTICALS INC.
To: MYLAN BERTEK PHARMACEUTICALS INC.
Reel/Frame 027354/0019 →
Change of Name
Dec 9, 2011
From: BERTEK, INC.
To: MYLAN TECHNOLOGIES, INC.
Reel/Frame 027361/0926 →
Change of Name
Dec 10, 2011
From: MLI ACQUISITION CORP. II
To: BERTEK, INC.
Reel/Frame 027370/0121 →
Change of Name
Dec 10, 2011
From: UDL LABORATORIES, INC.
To: MYLAN INSTITUTIONAL
Reel/Frame 027370/0119 →
Assignment of Assignor's Interest
Dec 10, 2011
From: PORA, RAYMOND I.
To: UDL LABORATORIES, INC.
Reel/Frame 027368/0173 →
Assignment of Assignor's Interest
Dec 10, 2011
From: KWIATEK, ALFRED; WEIMANN, LUDWIG J.; POLLOCK, WAYNE C.; GOVIL, SHARAD K.
To: MLI ACQUISITION CORP. II
Reel/Frame 027370/0031 →
Assignment of Assignor's Interest
Dec 10, 2011
From: WICK, JOHN; WEIMANN, LUDWIG J.; POLLOCK, WAYNE C.
To: BERTEK, INC.
Reel/Frame 027368/0761 →
Assignment of Assignor's Interest
Dec 10, 2011
From: BERTEK, INC.
To: MLI ACQUISITION CORP. II
Reel/Frame 027370/0039 →
Change of Name
Dec 10, 2011
From: BERTEK, INC.
To: MYLAN TECHNOLOGIES, INC.
Reel/Frame 027370/0113 →
Change of Name
Dec 11, 2011
From: MLI AQUISITION CORP. II
To: BERTEK, INC.
Reel/Frame 027363/0462 →
Assignment of Assignor's Interest
Dec 11, 2011
From: WICK, JOHN; WEIMANN, LUDWIG J.; POLLOCK, WAYNE C.
To: BERTEK, INC.
Reel/Frame 027362/0544 →
Assignment of Assignor's Interest
Dec 11, 2011
From: BERTEK, INC.
To: MLI ACQUISITION CORP. II
Reel/Frame 027362/0551 →
Patent Release
Dec 10, 2012
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: DEY PHARMA L.P. (F/K/A DEY, L.P.); MYLAN PHARMACEUTICALS, INC.; MYLAN BERTEK PHARMACEUTICALS INC.; MYLAN TECHNOLOGIES, INC.
Reel/Frame 029440/0967 →
Assignment of Assignor's Interest
Dec 29, 2022
From: GOMES DA COSTA, EVERTON
To: NICOLAAS JOSEF SCHOENMAKER E OUTROS
Reel/Frame 062237/0116 →